Lelantos Holdings, Inc. Achieves OTC Level 2 Quotation and Joins Improved Disclosure Service

Lelantos Holdings, Inc. (OTC PINK: LNTO) has reached a significant milestone by qualifying for OTC Level 2 quotations on the OTC Markets platform. This advancement provides investors with enhanced real-time trading visibility and market transparency, offering detailed bid and ask data across all market makers for a deeper insight into stock activity. Nathan Puente, CEO of Lelantos Holdings, highlighted this achievement as a pivotal step in the company's capital markets strategy, underscoring the importance of transparency and investor trust in the company's growth trajectory.

In addition to securing OTC Level 2 quotations, Lelantos Holdings has also been approved to join the OTC Markets’ Improved Disclosure Service starting July 2025. Joshua Weaver, COO of the company, expressed that this move is a testament to Lelantos' unwavering commitment to regulatory alignment and long-term investor confidence. The Improved Disclosure Service is designed to provide investors with timely and comprehensive information, further solidifying Lelantos Holdings' position as a transparent and reliable entity in the market.

These developments are particularly noteworthy for investors and stakeholders in the sustainable energy sector, where Lelantos Holdings aims to be at the forefront of innovation. The company's strategic focus on acquiring or joint venturing with established entities in key market sectors, coupled with its dedication to reducing overhead and increasing service offerings through vertical integration, positions it as a potentially transformative player in the industry. The approval for OTC Level 2 quotations and the Improved Disclosure Service not only enhance Lelantos Holdings' market presence but also contribute to the broader goal of fostering innovation and advancing technological developments in sustainable energy.